Active Biotech to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
< p > ANYARA - a novel cancer targeted therapy - is in Phase III trials with 500 advanced renal cell cancer patients. < /p > < p > 05/15/2008 < /p >
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Conferences | Kidney Cancer | Renal Cell Carcinoma | Urology & Nephrology